Ali Reza Biglari (Alireza Biglari)

Years Active: 2018-2024
Publications (10 Years): 5

University of Manchester (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Manchester

United Kingdom

PHD

Publications

Arezoo Beig Parikhani, Rada Dehghan, Yeganeh Talebkhan Garoosi, Elham Bayat, Ali Reza Biglari, Mohammad Ali Shokrgozar, Reza Ahangari Cohan, Esmat Mirabzadeh, Soheila Ajdary, Mahdi Behdani
A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic. AMB Express 14 (1) (2024)
Arezoo Beig Parikhani, Rada Dehghan, Yeganeh Talebkhan Garoosi, Elham Bayat, Ali Reza Biglari, Mohammad Ali Shokrgozar, Reza Ahangari Cohan, Esmat Mirabzadeh, Soheila Ajdary, Mahdi Behdani
A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic. AMB Express 14 (1) (2024)
Keivan Nedaei, Mahdi Hesaraki, Saeideh Mazloumzadeh, Mehdi Totonchi, Ali Reza Biglari
Lentiviral Mediated Expression of Soluble Neuropilin 1 Inhibits Semaphorin 3A-mediated Collapse Activity in Vitro . Basic and clinical neuroscience 12 (2) (2021)
Madiheh Mazaheri Moghaddam, Marziyeh Mazaheri Moghaddam, Mohammad Amini, Behzad Bahramzadeh, Amir Baghbanzadeh, Ali Reza Biglari, Ebrahim Sakhinia
Evaluation of SEPT2 and SEPT4 transcript contents in spermatozoa from men with asthenozoospermia and teratozoospermia. Health science reports 4 (4) (2021)
Ardavan Ghazanchaei, Behzad Mansoori, Ali Mohammadi, Ali Reza Biglari, Behzad Baradaran
Restoration of miR-152 expression suppresses cell proliferation, survival, and migration through inhibition of AKT-ERK pathway in colorectal cancer. Journal of cellular physiology 234 (1) (2018)

Ali Reza Biglari.css-eqlu8i{font-size:small;padding-left:4px;} (Alireza Biglari)